Literature DB >> 8439199

Gall bladder contractility in preterm infants.

L Lehtonen1, E Svedström, P Kero, H Korvenranta.   

Abstract

Postnatal response of the gall bladder to feeding was studied in 28 preterm infants (gestational age 24-37 weeks) by ultrasonography immediately before feeding and one hour after feeding. Nineteen of the infants were studied once during the first week of life, and nine infants were studied weekly from a postconceptional age of 27-31 until a postprandial gall bladder contraction was seen. A contraction index was calculated as a percentage decrement of the surface area of the gall bladder from its initial value. All preterm infants of more than 33 weeks' gestation showed a gall bladder response to feeding with a contraction index of at least 50%. Very preterm infants (gestational age 27-32 weeks) showed no postprandial gall bladder contraction or the contraction index was under 50%. In a follow up study of nine very preterm infants, the contraction index exceeded 50% at a postconceptional age of 29 to 32 weeks. One infant with prolonged feeding problems had no postprandial gall bladder response before the postconceptional age of 38 weeks. The contraction index increase was dependent on gestational age at birth and on the bolus volume of feeds.

Entities:  

Mesh:

Year:  1993        PMID: 8439199      PMCID: PMC1029167          DOI: 10.1136/adc.68.1_spec_no.43

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  7 in total

1.  Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction.

Authors:  R A Liddle; I D Goldfine; M S Rosen; R A Taplitz; J A Williams
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

2.  Postprandial motor response of the small intestine to enteral feeds in preterm infants.

Authors:  W M Bisset; J Watt; R P Rivers; P J Milla
Journal:  Arch Dis Child       Date:  1989-10       Impact factor: 3.791

3.  Ontogeny of fasting small intestinal motor activity in the human infant.

Authors:  W M Bisset; J B Watt; R P Rivers; P J Milla
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

4.  Oral administration of loxiglumide (CCK antagonist) inhibits postprandial gallbladder contraction without affecting gastric emptying.

Authors:  E Corazziari; R Ricci; D Biliotti; I Bontempo; A De Medici; N Pallotta; A Torsoli
Journal:  Dig Dis Sci       Date:  1990-01       Impact factor: 3.199

5.  Quantitative comparison of the effects of cholecystokinin, secretin, and pentagastrin on gastrointestinal myoelectric activity in the conscious fasted dog.

Authors:  D L Wingate; E A Pearce; M Hutton; A Dand; H H Thompson; E Wünsch
Journal:  Gut       Date:  1978-07       Impact factor: 23.059

6.  Metabolic and endocrine events at the time of the first feed of human milk in preterm and term infants.

Authors:  A Lucas; S R Bloom; A Aynsley-Green
Journal:  Arch Dis Child       Date:  1978-09       Impact factor: 3.791

7.  The effect of loxiglumide (CR-1505) on basal and bombesin-stimulated gallbladder volume in man.

Authors:  B R Douglas; M C Jebbink; R T Tjon a Tham; J B Jansen; C B Lamers
Journal:  Eur J Pharmacol       Date:  1989-07-18       Impact factor: 4.432

  7 in total
  3 in total

1.  Magnetic resonance imaging of the fetal gallbladder and bile.

Authors:  Peter C Brugger; Michael Weber; Daniela Prayer
Journal:  Eur Radiol       Date:  2010-06-20       Impact factor: 5.315

2.  Gall bladder contractility in neonates: effects of parenteral and enteral feeding.

Authors:  G Jawaheer; A Pierro; D A Lloyd; N J Shaw
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-05       Impact factor: 5.747

3.  Volumetric Analysis of Gallbladder in Extremely Premature Infants.

Authors:  Takashi Imamura; Maki Sato; Hayato Go; Kei Ogasawara; Yuji Kanai; Mina Chishiki; Hajime Maeda; Kentarou Haneda; Nozomi Kashiwabara; Aya Goto; Nobuo Momoi; Mitsuaki Hosoya
Journal:  J Med Ultrasound       Date:  2017-03-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.